Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000222856 | SCV000269066 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | p.Ser395Asn in exon 5 of EDNRB: This variant is not expected to have clinical si gnificance because it has been identified in 1.4% (119/8600) of European America n chromosomes from a broad population by the NHLBI Exome Sequencing Project (htt p://evs.gs.washington.edu/EVS; dbSNP rs5352). |
Prevention |
RCV000222856 | SCV000302327 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000018118 | SCV000384810 | uncertain significance | Hirschsprung disease, susceptibility to, 2 | 2018-03-06 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Laboratory of Human Genetics, |
RCV000626404 | SCV000678739 | likely benign | Waardenburg syndrome type 2A | 2017-03-01 | criteria provided, single submitter | research | |
Eurofins Ntd Llc |
RCV000222856 | SCV000707740 | benign | not specified | 2017-05-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000954472 | SCV000727101 | benign | not provided | 2019-05-10 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22995991, 26764160, 27535533, 10874640, 8852659, 21507037) |
Center for Human Genetics, |
RCV000659497 | SCV000781315 | likely benign | Waardenburg syndrome type 4A | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000954472 | SCV001101107 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000954472 | SCV001143835 | benign | not provided | 2018-12-29 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV001258252 | SCV001435166 | benign | Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant | criteria provided, single submitter | research | The heterozygous p.Ser305Asn variant, sometimes called p.Ser205Asn or p.Ser295Asn, in EDNRB has been identified in at least 6 individuals with Hirschsprung disease, including 4 relatives from 1 family (PMID: 8852659, 10874640, 22995991). However, this variant does not segregate with disease (PMID: 10874640), and has been identified in >2% of European (Finnish) chromosomes and 5 homozygotes in ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for Hirschsprung disease. | |
Ce |
RCV000954472 | SCV004133216 | benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | EDNRB: BS1, BS2 |
OMIM | RCV000018118 | SCV000038397 | risk factor | Hirschsprung disease, susceptibility to, 2 | 1999-04-01 | no assertion criteria provided | literature only |